Steven Kliewer
From Wikipedia the free encyclopedia
Steven Kliewer is an American biochemist, a significant figure in his field, currently the Nancy B. and Jake L. Hamon Distinguished Chair in Basic Cancer Research at University of Texas Southwestern Medical Center. In 2015, he was elected to the National Academy of Sciences. He, along with David Mangelsdorf, identified the ligands and physiologic functions of a number of orphan nuclear receptors that then discovered two new signaling pathways mediated by the endocrine factors FGF19 and FGF21, which has become a significant accomplishment in the field.[1][2][3]
References[edit]
- ^ "Steven Kliewer". utsouthwestern.edu. Retrieved February 25, 2017.
- ^ "Principal Investigators". utsouthwestern.edu. Retrieved February 25, 2017.
- ^ "Hooper and Kliewer elected to prestigious National Academy of Sciences". utsouthwestern.edu. April 28, 2015. Retrieved February 25, 2017.
| International | |
|---|---|
| National | |
| Academics | |
   | This biographical article about an American chemist is a stub. You can help Wikipedia by expanding it. |